FDA Import Refusal AEK-7725026-1/21/1 — Glenmark Pharmaceuticals Limited
The FDA refused shipment AEK-7725026-1/21/1 from Glenmark Pharmaceuticals Limited (India) on August 24, 2020. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 24, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ODA14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
- Charges
- 75